2022 Ljubljana, Slovenia
Meeting information
Program
Abstracts
Programme Item
Presenter
Abstract Category
Search Abstract
II-18 Yin Edwards
Exposure-safety analysis of Tovorafenib (DAY101), an investigational oral pan-RAF kinase inhibitor, in oncology patients with solid tumors
Wednesday 15:10-16:40